Yasushi Suwazono Selected Research

Cadmium Poisoning (Itai Itai)

5/2021	The relationship between cadmium exposure and renal volume in inhabitants of a cadmium-polluted area of Japan.
7/2017	Causes of death in patients with Itai-itai disease suffering from severe chronic cadmium poisoning: a nested case-control analysis of a follow-up study in Japan.
1/2017	Threshold limit values of the cadmium concentration in rice in the development of itai-itai disease using benchmark dose analysis.
3/2009	Influence of consumption of cadmium-polluted rice or Jinzu River water on occurrence of renal tubular dysfunction and/or Itai-itai disease.
1/2009	Influence of drinking and/or cooking with Jinzu River water on the development of Itai-itai disease.
11/2005	Estimation of cumulative cadmium intake causing Itai-itai disease.
10/2004	Environmental cadmium exposure, adverse effects and preventive measures in Japan.
8/2004	Relationship among prevalence of patients with Itai-itai disease, prevalence of abnormal urinary findings, and cadmium concentrations in rice of individual hamlets in the Jinzu River basin, Toyama prefecture of Japan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasushi Suwazono Research Topics

Disease

10	Hypertension (High Blood Pressure) 11/2021 - 03/2004
8	Cadmium Poisoning (Itai Itai) 05/2021 - 08/2004
4	Hyperuricemia 11/2016 - 01/2006
4	Obesity 05/2016 - 01/2006
4	Hypercholesterolemia 10/2014 - 01/2006
4	Overweight 05/2014 - 01/2004
3	Neoplasms (Cancer) 01/2022 - 04/2018
3	Renal Insufficiency (Renal Failure) 10/2020 - 01/2018
3	Proteinuria 04/2018 - 03/2002
3	Isolated Systolic Hypertension 01/2009 - 12/2005
2	Insulin Resistance 01/2017 - 10/2014
2	Stroke (Strokes) 07/2013 - 01/2006
2	Osteoporosis 03/2011 - 08/2010
2	Diabetes Mellitus 05/2006 - 06/2005
1	Glucose Intolerance 05/2021
1	Hypotension (Low Blood Pressure) 01/2021
1	Lung Neoplasms (Lung Cancer) 04/2018
1	Uterine Neoplasms (Uterine Cancer) 04/2018
1	Prostatic Neoplasms (Prostate Cancer) 04/2018
1	Urologic Diseases (Urinary Tract Disease) 01/2018
1	Poisoning 07/2017
1	Bone Diseases (Bone Disease) 01/2017
1	Iron Overload 01/2017
1	Type 2 Diabetes Mellitus (MODY) 05/2016
1	Inflammation (Inflammations) 12/2014
1	Wrist Fractures 03/2011
1	Osteoporotic Fractures 03/2011
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2011
1	Metabolic Bone Diseases (Osteopenia) 08/2010
1	Acidosis 08/2008
1	Glycosuria 03/2002

Drug/Important Bio-Agent (IBA)

16	CadmiumIBA 01/2022 - 01/2003
7	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2021 - 06/2005
7	Uric Acid (Urate)IBA 11/2016 - 03/2004
6	CreatinineIBA 01/2020 - 12/2005
5	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 05/2011 - 03/2004
5	Antihypertensive Agents (Antihypertensives)IBA 01/2009 - 03/2004
4	CholesterolIBA 05/2011 - 01/2006
4	G-protein beta3 subunitIBA 06/2006 - 01/2004
2	Ethanol (Ethyl Alcohol)IBA 11/2021 - 11/2016
2	GTP-Binding Proteins (G-Protein)IBA 05/2014 - 01/2006
2	Transaminases (Aminotransferases)IBA 05/2011 - 02/2008
2	Guanosine Triphosphate (GTP)IBA 02/2008 - 03/2004
2	Low Density Lipoprotein Receptor-Related Protein-5IBA 06/2006 - 01/2006
1	Hexosaminidases (Hexosaminidase)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 05/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	Anesthetics (Anesthetic Agents)IBA 01/2021
1	antineoplaston A10 (A 10)IBA 10/2020
1	Ferritins (Ferritin)IBA 01/2017
1	CarbohydratesIBA 05/2016
1	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 05/2016
1	C-Reactive ProteinIBA 12/2014
1	Insulin (Novolin)FDA Link 10/2014
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2014
1	Biological FactorsIBA 07/2013
1	ORALIT (ORS)IBA 03/2011
1	Vascular Endothelial Growth Factor DIBA 01/2011
1	Biological ProductsIBA 08/2008
1	Gout Suppressants (Antigout Agents)IBA 06/2006
1	Serotonin ReceptorsIBA 01/2006
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2006
1	HDL CholesterolIBA 01/2006
1	LipidsIBA 01/2006
1	Indicators and Reagents (Reagents)IBA 12/2004
1	Glucose (Dextrose)FDA LinkGeneric 03/2002
1	Proteins (Proteins, Gene)FDA Link 03/2002

Therapy/Procedure

1	General Anesthesia 01/2021
1	Anesthesia 01/2021
1	Bathroom Equipment 01/2018